ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines.

Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon.
With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.

Biotechnology

ProBioGen AG

Ingo Jordan

Julian Collins

Jana Windt

Claudia Conert

Dr. Sascha Ramm

Lukas Rositzka

Tanja Arnouk

Anastasia Piltsi

Christian Auerbach

Dirk Matthias

Kevin Pommerencke

Stefan Schulz

Tim Wonnecke

Christian Herrberger

Holger Bernhardt

Michiel Stork

Andrea Naujoks

Andrea Hauptmann

Katharina Vogdt

Rita Bhattacherjee

The Scientists and Researchers team at ProBioGen AG is responsible for advancing cell line engineering, process development, and GMP manufacturing for biopharmaceutical clients. They conduct rigorous quality control (QC) analysis, develop vaccine strategies, and perform protein analytics. This team plays a crucial role in optimizing biopharmaceutical manufacturing and ensuring the high-quality development of viral vaccines, leveraging innovative technologies and over 25 years of expertise in animal cell culture.

Scientists and Researchers

Production and Development

Engineering and Process Development

Scientists and Researchers

About

Team members

Other teams at ProBioGen AG

Production and Development

Engineering and Process Development